48
Participants
Start Date
June 30, 2009
Primary Completion Date
December 31, 2009
Study Completion Date
April 30, 2010
Nimotuzumab and chemotherapy
"Experimental: Nimotuzumab and Irinotecan~the chemotherapy treatment: Irinotecan (180 mg/m2/time, 1 time/14 days, until disease progression)~the nimotuzumab treatment: 3 levels (200 mg/w, 400 mg/w, 600 mg/w, weekly, until disease progression)"
NOT_YET_RECRUITING
Sun Yat-Sen University Cancer Center, Guangzhou
RECRUITING
Peking University, School of Oncology, Beijing Cancer Hospital & Institute, Beijing
NOT_YET_RECRUITING
China People's Liberation Army (PLA)81 Hospital, Nanjing
Collaborators (1)
Biotech Pharmaceutical Co., Ltd.
OTHER
Peking University
OTHER